CLINICAL_TRIALS
research
· 2026-02-17
Clinical Trial Update: Randomized Trial of stAndard of Care With or Without Metastases-directed Stereotactic Body Radiation Therapy in Patients Affected by Oligometastatic uRothelial carcinomA [NA]
Summary
A randomized trial is evaluating whether adding metastasis-directed stereotactic body radiation therapy to standard of care improves outcomes in oligometastatic…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Istituto Clinico Humanitas | Conditions: Bladder Cancer, Urothelial Carcinoma (UC) | NA | Status: NOT_YET_RECRUITING